Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

Повний опис

Бібліографічні деталі
Автори:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
Формат:	Стаття
Мова:	English
Опубліковано:	Taylor & Francis Group 2017-04-01
Серія:	Expert Review of Vaccines
Предмети:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
Онлайн доступ:	http://dx.doi.org/10.1080/14760584.2017.1294068

Схожі ресурси

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
за авторством: Piyada Angsuwatcharakon, та інші
Опубліковано: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
за авторством: Jia Li, та інші
Опубліковано: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
за авторством: D.J. Briggs, та інші

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
за авторством: Jing Wang, та інші
Опубліковано: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
за авторством: A. L. Kravtsov, та інші
Опубліковано: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
за авторством: Hua-Kun Lv, та інші
Опубліковано: (2025-02-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
за авторством: Scott Preiss, та інші
Опубліковано: (2018-06-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
за авторством: Lidong Wang, та інші
Опубліковано: (2024-03-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
за авторством: Nianmin Shi, та інші
Опубліковано: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
за авторством: Zheng-Gang Zhu, та інші
Опубліковано: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
за авторством: Jia Li, та інші
Опубліковано: (2024-12-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
за авторством: Pornthep Chanthavanich, та інші
Опубліковано: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
за авторством: Xiaohong Wu, та інші
Опубліковано: (2023-08-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
за авторством: Gagandeep Kang, та інші
Опубліковано: (2023-07-01)

Infection and Prevention of Rabies Viruses
за авторством: Shiu-Jau Chen, та інші
Опубліковано: (2025-02-01)

Development of mRNA rabies vaccines
за авторством: Zixin Fang, та інші
Опубліковано: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
за авторством: Thomas Moulenat, та інші
Опубліковано: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
за авторством: Zhenzhen Liang, та інші
Опубліковано: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
за авторством: Lei Zhang, та інші
Опубліковано: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
за авторством: S. V. Generalov, та інші
Опубліковано: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
за авторством: Xingyu Zhou, та інші
Опубліковано: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
за авторством: Heng Shen, та інші
Опубліковано: (2021-02-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
за авторством: Pooneh Rahimi, та інші
Опубліковано: (2014-08-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
за авторством: E. G. Abramova, та інші
Опубліковано: (2019-11-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
за авторством: Xiaoyuan Huang, та інші
Опубліковано: (2023-01-01)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
за авторством: Hanna K, та інші
Опубліковано: (2018-06-01)

Retrospective study of rabies epidemiology in Ukraine (1950-2019)
за авторством: I. F. Makovska, та інші
Опубліковано: (2020-03-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
за авторством: Irina Matveeva, та інші
Опубліковано: (2022-09-01)

Management of rabies
за авторством: J. Weyer, та інші
Опубліковано: (2019-07-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
за авторством: Emily G Pieracci, та інші
Опубліковано: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
за авторством: Sunil Karande, та інші
Опубліковано: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
за авторством: SILVA Jorgete M., та інші
Опубліковано: (1997-01-01)

A case of human survival of rabies, South Africa
за авторством: Jacqueline Weyer, та інші
Опубліковано: (2016-07-01)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
за авторством: Weerawan Hattasingh, та інші
Опубліковано: (2022-01-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
за авторством: Jun Luo, та інші
Опубліковано: (2020-04-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
за авторством: Gadey Sampath, та інші
Опубліковано: (2017-07-01)

Factors related to vaccines for both patients exposed with rabies and dogs
за авторством: Lam Quy Ngo, та інші
Опубліковано: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
за авторством: Lam Quy Ngo, та інші
Опубліковано: (2022-03-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
за авторством: Anurag Agarwal, та інші
Опубліковано: (2022-11-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
за авторством: Mahdika Ambarwaty, та інші
Опубліковано: (2023-12-01)